Advanced
  Home Compare Reports

Comparison with Similar Reports

Infection Control Market by Product [Sterilization (Steam, Hydrogen Peroxide, EtO), Disinfection (Wipes, Liquids, Disinfectors), Services, E-beam, Fac...

Publisher:        MarketsandMarkets

# of Pages:        529

Rating: 

1 User License $4,950

Publication Date:  May, 2021

Price:       $4,950 / User License




1 INTRODUCTION 62
1.1 OBJECTIVES OF THE STUDY 62
1.2 MARKET DEFINITION & SCOPE 62
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 62
1.2.2 MARKETS COVERED 63
FIGURE 1 INFECTION CONTROL MARKET SEGMENTATION 63
1.2.3 YEARS CONSIDERED FOR THE STUDY 64
1.3 CURRENCY 64
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 64
1.4 STAKEHOLDERS 65
1.5 LIMITATIONS 65
1.6 SUMMARY OF CHANGES 65
2 RESEARCH METHODOLOGY 67
2.1 RESEARCH APPROACH 67
FIGURE 2 RESEARCH DESIGN 67
2.1.1 SECONDARY RESEARCH 68
2.1.1.1 Key data from secondary sources 69
2.1.2 PRIMARY RESEARCH 69
2.1.2.1 Primary sources 70
2.1.2.2 Key data from primary sources 71
2.1.2.3 Insights from primary experts 72
2.1.2.4 Breakdown of primaries 73
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 73
2.2 MARKET SIZE ESTIMATION 73
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 74
FIGURE 5 STERILIZATION MARKET - REVENUE SHARE ANALYSIS ILLUSTRATION: STERIS 74
FIGURE 6 ENDOSCOPE REPROCESSING MARKET - REVENUE SHARE ANALYSIS ILLUSTRATION: CANTEL MEDICAL 75
FIGURE 7 MARKET ANALYSIS APPROACH 76
FIGURE 8 TOP-DOWN APPROACH 76
FIGURE 9 CAGR PROJECTIONS 77
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE INFECTION CONTROL MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR 78
2.3 DATA TRIANGULATION APPROACH 80
FIGURE 11 DATA TRIANGULATION METHODOLOGY 80
2.4 MARKET SHARE ESTIMATION 81
2.5 ASSUMPTIONS FOR THE STUDY 81
2.6 RISK ASSESSMENT 82
TABLE 2 RISK ASSESSMENT: INFECTION CONTROL MARKET 82
3 EXECUTIVE SUMMARY 83
FIGURE 12 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 84
FIGURE 13 STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 84
FIGURE 14 CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 85
FIGURE 15 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 86
FIGURE 16 PROTECTIVE BARRIERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 86
FIGURE 17 INFECTION CONTROL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 87
FIGURE 18 GEOGRAPHIC ANALYSIS: INFECTION CONTROL MARKET 88
4 PREMIUM INSIGHTS 90
4.1 INFECTION CONTROL MARKET OVERVIEW 90
FIGURE 19 GROWING INCIDENCE OF HAIS AND INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 90
4.2 ASIA PACIFIC: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE AND COUNTRY 91
FIGURE 20 PROTECTIVE BARRIERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 91
4.3 INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 92
FIGURE 21 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 92
4.4 INFECTION CONTROL MARKET, BY REGION (2019–2026) 93
FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE INFECTION CONTROL MARKET DURING THE FORECAST PERIOD 93
4.5 INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS 94
FIGURE 23 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 94
5 MARKET OVERVIEW 95
5.1 INTRODUCTION 95
5.2 MARKET DYNAMICS 95
TABLE 3 INFECTION CONTROL MARKET: IMPACT ANALYSIS 95
5.2.1 MARKET DRIVERS 96
5.2.1.1 High incidence of hospital-acquired infections (HAIs) 96
5.2.1.2 Increasing number of surgical procedures 98
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 98
5.2.1.3 Growing geriatric population and the increasing incidence of chronic diseases 99
5.2.1.4 Growing focus on food sterilization and disinfection 100
5.2.1.5 Technological advancements in sterilization equipment 100
5.2.1.6 Increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers 101
5.2.1.7 Growing awareness of environmental & personal hygiene due to COVID-19 101
5.2.2 MARKET RESTRAINTS 102
5.2.2.1 Concerns regarding the safety of reprocessed instruments 102
5.2.2.2 Adverse effects of chemical disinfectants 102
5.2.2.3 High cost of endoscopy reprocessing and limited reimbursement in developing countries 103
5.2.3 MARKET OPPORTUNITIES 103
5.2.3.1 Growing medical device and pharmaceutical companies in emerging economies 103
FIGURE 24 MEDICAL DEVICES MARKET, 2016−2020 (USD BILLION) 104
5.2.3.2 Increasing use of E-beam sterilization 105
5.2.3.3 Reintroduction of ethylene oxide sterilization 105
5.2.3.4 Rising adoption of single-use medical nonwovens and devices 106
5.2.3.5 Growing healthcare industry and outsourcing of operations to emerging countries 106
FIGURE 25 INDIA: NUMBER OF HOSPITALIZATIONS DUE TO VARIOUS DISEASES 107
5.2.4 MARKET CHALLENGES 108
5.2.4.1 Sterilization and disinfection of advanced medical instruments 108
5.2.4.2 End-user noncompliance with sterilization standards 108
TABLE 5 US: DECREASING COMPLIANCE AMONG END USERS 109
5.2.4.3 Development of alternative technologies for surface disinfection 109
6 INDUSTRY INSIGHTS 110
6.1 INTRODUCTION 110
6.2 INDUSTRY TRENDS 110
6.2.1 LAYERING/BUNDLING IN INFECTION PREVENTION 110
6.2.2 ROBOTICS UTILIZATION FOR DISINFECTION 111
6.2.3 GROWING POPULARITY OF SINGLE-USE PRODUCTS 112
6.3 REGULATORY ANALYSIS 112
6.3.1 REGULATORY JURISDICTION 112
TABLE 6 FDA AND EPA REGISTERED PRODUCT CATEGORIES 113
6.3.2 BY REGION 113
6.3.2.1 North America 113
6.3.2.1.1 US 113
FIGURE 26 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES 114
6.3.2.1.2 Canada 114
TABLE 7 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING 115
6.3.2.2 Europe 115
TABLE 8 STERILIZATION STANDARDS IN THE EUROPEAN UNION 116
FIGURE 27 CE MARKING FOR REPROCESSED MEDICAL DEVICES 116
6.3.2.3 Asia Pacific 117
6.3.2.3.1 Japan 117
TABLE 9 GUIDELINES FOR INDICATORS 117
TABLE 10 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES 118
6.3.2.3.2 China 118
6.3.2.3.3 Australia 118
6.3.3 ENFORCEMENT POLICY FOR STERILIZERS AND DISINFECTANT DEVICES DURING COVID-19 119
6.3.3.1 Sterilizers 119
TABLE 11 CLASSIFICATION REGULATIONS FOR STERILIZERS 119
6.3.3.2 Disinfectant devices 119
TABLE 12 CLASSIFICATION REGULATION FOR DISINFECTANT DEVICES 120
6.3.3.3 Policies 120
6.4 TECHNOLOGY ANALYSIS 121
6.4.1 SUPERCRITICAL CO2 TECHNOLOGY 122
6.4.2 ULTRA-HIGH-PRESSURE STERILIZATION 122
6.4.3 NITROGEN DIOXIDE (NO2) 122
6.4.4 PULSED ELECTRIC FIELD (PEF) STERILIZATION 123
6.4.5 PLASMA STERILIZATION 123
6.5 PORTER’S FIVE FORCES ANALYSIS 124
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 124
6.5.1 THREAT OF NEW ENTRANTS 124
6.5.2 THREAT OF SUBSTITUTES 124
6.5.3 BARGAINING POWER OF SUPPLIERS 125
6.5.4 BARGAINING POWER OF BUYERS 125
6.5.5 INTENSITY OF COMPETITIVE RIVALRY 125
6.6 ECOSYSTEM ANALYSIS 125
FIGURE 28 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS 126
6.7 VALUE CHAIN ANALYSIS 127
FIGURE 29 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS 127
FIGURE 30 FOOD DISINFECTANTS MARKET: VALUE CHAIN ANALYSIS 128
6.8 TRADE DATA 128
6.8.1 EXPORT DATA (USD) 128
6.8.2 IMPORT DATA (USD) 129
6.9 PATENT ANALYSIS 129
6.9.1 PATENT PUBLICATION TRENDS FOR INFECTION CONTROL 129
FIGURE 31 PATENT PUBLICATION TRENDS (2015–2021) 130
6.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 130
FIGURE 32 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR INFECTION CONTROL PATENTS (JANUARY 2015– MARCH 2021) 131
FIGURE 33 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION CONTROL PATENTS (JANUARY 2015–MARCH 2021) 131
6.10 IMPACT OF COVID-19 ON THE INFECTION CONTROL MARKET 132
TABLE 14 ADJACENT MARKETS AND THEIR CURRENT GROWTH 133
7 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE 134
7.1 INTRODUCTION 135
TABLE 15 COMMONLY USED INFECTION CONTROL CHEMICALS 135
TABLE 16 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 137
7.2 STERILIZATION PRODUCTS & SERVICES 137
TABLE 17 STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 18 STERILIZATION PRODUCTS & SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
7.2.1 STERILIZATION EQUIPMENT 139
TABLE 19 STERILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 20 STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 140
7.2.1.1 Heat sterilization equipment 140
TABLE 21 HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 22 HEAT STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
7.2.1.1.1 Moist heat sterilizers 142
7.2.1.1.1.1 Moist heat sterilizers dominate the heat sterilization equipment market 142
TABLE 23 MOIST HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 143
TABLE 24 MOIST HEAT STERILIZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
7.2.1.1.2 Dry heat sterilizers 144
7.2.1.1.2.1 Increasing use of dry heat sterilizers for the sterilization of heat-resistant instruments to drive market growth 144
TABLE 25 DRY HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 145
TABLE 26 DRY HEAT STERILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 146
7.2.1.2 Low-temperature sterilization equipment 146
TABLE 27 LOW-TEMPERATURE STERILIZERS OFFERED BY KEY MARKET PLAYERS 147
TABLE 28 LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 29 LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 148
7.2.1.2.1 Hydrogen peroxide sterilization 148
7.2.1.2.1.1 Hydrogen peroxide sterilization segment to register the highest growth rate in the low-temperature sterilization equipment market 148
TABLE 30 HYDROGEN PEROXIDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 149
TABLE 31 HYDROGEN PEROXIDE STERILIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
7.2.1.2.2 Ethylene oxide (EtO) sterilization 150
7.2.1.2.2.1 Widespread applications of EtO and high penetrative capabilities are the key factors driving market growth 150
TABLE 32 ETO STERILIZERS OFFERED BY KEY MARKET PLAYERS 151
TABLE 33 ETO STERILIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 152
7.2.1.2.3 Formaldehyde sterilization 152
7.2.1.2.3.1 Effectiveness of formaldehyde sterilizers to sterilize heat-sensitive goods to support market growth 152
TABLE 34 FORMALDEHYDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 153
TABLE 35 FORMALDEHYDE STERILIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 153
7.2.1.2.4 Other low-temperature sterilization 154
TABLE 36 OTHER LOW-TEMPERATURE STERILIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 155
7.2.1.3 Radiation sterilization equipment 155
7.2.1.3.1 Wide use of radiation sterilization across pharmaceutical products, medical devices, and tissue samples to drive the market 155
TABLE 37 RADIATION STERILIZERS OFFERED BY KEY MARKET PLAYERS 157
TABLE 38 RADIATION STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
7.2.1.4 Filtration sterilization equipment 158
7.2.1.4.1 Growing need for the elimination of bioburden from non-sterile drug substances to drive this market 158
TABLE 39 FILTRATION STERILIZERS OFFERED BY KEY MARKET PLAYERS 158
TABLE 40 FILTRATION STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 160
7.2.1.5 Other sterilization equipment 160
TABLE 41 OTHER STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 161
7.2.2 CONTRACT STERILIZATION SERVICES MARKET 161
TABLE 42 CONTRACT STERILIZATION SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 43 CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 163
7.2.2.1 EtO sterilization services 163
7.2.2.1.1 Reintroduction of EtO sterilization to support market growth 163
TABLE 44 ETO STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 164
TABLE 45 ETO STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 165
7.2.2.2 Gamma sterilization services 165
7.2.2.2.1 Increasing use of gamma sterilization services in the life sciences industry to drive market growth 165
TABLE 46 GAMMA STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 166
TABLE 47 GAMMA STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 167
7.2.2.3 E-beam sterilization services 167
7.2.2.3.1 E-beam sterilization services to register the fastest growth during the forecast period 167
TABLE 48 E-BEAM STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 168
7.2.2.4 Steam sterilization services 169
7.2.2.4.1 Growing adoption of steam sterilization services in the food industry to aid market growth 169
TABLE 49 STEAM STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 170
7.2.2.5 Other contract sterilization services 170
TABLE 50 KEY PLAYERS OFFERING OTHER CONTRACT STERILIZATION SERVICES 172
TABLE 51 OTHER CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 172
7.2.3 CONSUMABLES & ACCESSORIES 173
TABLE 52 CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 53 CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
7.2.3.1 Sterilization indicators 174
TABLE 54 STERILIZATION INDICATORS OFFERED BY KEY MARKET PLAYERS 175
TABLE 55 STERILIZATION INDICATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 56 STERILIZATION INDICATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 176
7.2.3.1.1 Chemical indicators 176
7.2.3.1.1.1 Low cost and ease of operation of chemical indicators to drive the market 176
TABLE 57 STEAM STERILIZATION CHEMICAL INDICATORS: CLASSIFICATION AND APPLICATION 177
TABLE 58 CHEMICAL INDICATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 178
7.2.3.1.2 Biological indicators 179
7.2.3.1.2.1 Efficacy of biological indicators in monitoring the sterilization process to increase its adoption 179
TABLE 59 BIOLOGICAL INDICATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 180
7.2.3.2 Packaging accessories 180
7.2.3.2.1 Increasing demand for sterilization packaging accessories to aid market growth 180
TABLE 60 TYPES OF HIGH-TEMPERATURE STERILIZATION AND SUITABLE STERILIZATION PACKAGING MATERIALS 181
TABLE 61 PACKAGING ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 182
7.3 CLEANING & DISINFECTION PRODUCTS 182
TABLE 62 JOINT COMMISSION STANDARDS FOR INFECTION CONTROL AND PREVENTION 183
TABLE 63 CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 64 CLEANING & DISINFECTION PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 184
7.3.1 DISINFECTANTS 185
TABLE 65 COMMON DISINFECTANTS USED IN INDUSTRIAL SETTINGS 186
TABLE 66 DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 187
7.3.1.1 Disinfectants, by type 187
TABLE 67 DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
7.3.1.1.1 Hand disinfectants 188
7.3.1.1.1.1 Increasing health awareness and availability of convenient hand disinfection options are expected to boost the market growth 188
TABLE 68 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 189
TABLE 69 HAND DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 190
7.3.1.1.2 Surface disinfectants 190
7.3.1.1.2.1 Surface disinfectants limit the transfer of microorganisms that can occur through hand contact between contaminated surfaces and patients or staff 190
TABLE 70 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 191
TABLE 71 SURFACE DISINFECTANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 192
7.3.1.1.3 Skin disinfectants 192
7.3.1.1.3.1 Rising awareness regarding SSIs and HAIs to drive the growth of the skin disinfectants market 192
TABLE 72 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 193
TABLE 73 SKIN DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 193
7.3.1.1.4 Instrument disinfectants 194
7.3.1.1.4.1 Increasing number of surgeries and government initiatives for ensuring cleanliness in healthcare facilities are boosting the instrument disinfectants market 194
TABLE 74 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT AND REQUIRED LEVEL OF REPROCESSING 195
TABLE 75 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 195
7.3.1.2 Disinfectants, by formulation 196
TABLE 76 DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION) 196
7.3.1.2.1 Liquid disinfectants 196
7.3.1.2.1.1 Liquid formulations are inexpensive and are an effective disinfection solution for porous and nonporous surfaces 196
TABLE 77 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 197
TABLE 78 LIQUID DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 198
7.3.1.2.2 Disinfectant wipes 198
7.3.1.2.2.1 Wipes help eliminate a broad spectrum of bacteria, viruses, and allergens 198
TABLE 79 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS 199
TABLE 80 DISINFECTANT WIPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 200
7.3.1.2.3 Disinfectant sprays 201
7.3.1.2.3.1 Disinfectant sprays are used in fogging techniques for antimicrobial control in hospital rooms and operation theaters 201
TABLE 81 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS 201
TABLE 82 DISINFECTANT SPRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 202
7.3.1.3 Disinfectants, by EPA classification 202
TABLE 83 CLASSIFICATION OF DISINFECTANTS 203
TABLE 84 DISINFECTANTS MARKET, BY EPA CLASSIFICATION,
2019–2026 (USD MILLION) 203
7.3.1.3.1 Low-level disinfectants 203
7.3.1.3.1.1 Low-level disinfectants dominated the market due to their widespread use on non-critical items and surfaces 203
TABLE 85 LOW-LEVEL DISINFECTANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 204
7.3.1.3.2 Intermediate-level disinfectants 204
7.3.1.3.2.1 Intermediate-level disinfectants are primarily used to disinfect surfaces in dental practices 204
TABLE 86 INTERMEDIATE-LEVEL DISINFECTANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 205
7.3.1.3.3 High-level disinfectants 205
7.3.1.3.3.1 High-level disinfectants are effective in disinfecting heat-sensitive, critical, and semi-critical items 205
TABLE 87 HIGH-LEVEL DISINFECTANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 206
7.3.2 CLEANING & DISINFECTION EQUIPMENT 206
TABLE 88 CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 89 CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 207
7.3.2.1 Washer disinfectors 208
7.3.2.1.1 Washer disinfectors are offered in single-chamber and multi-chamber formats 208
TABLE 90 WASHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 208
TABLE 91 WASHER DISINFECTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 209
7.3.2.2 Flusher disinfectors 210
7.3.2.2.1 Growing need to reduce the spread of HAIs is driving market growth 210
TABLE 92 FLUSHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 210
TABLE 93 FLUSHER DISINFECTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 211
7.3.2.3 UV-ray disinfectors 211
7.3.2.3.1 UV-ray disinfectors are considered an environmentally friendly, chemical-free, and effective method of disinfection 211
TABLE 94 UV-RAY DISINFECTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 212
7.3.2.4 Ultrasonic cleaners 212
7.3.2.4.1 Ultrasonic cleaners effectively disinfect intricate medical instruments 212
TABLE 95 ULTRASONIC CLEANERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 213
7.3.2.5 Other cleaning and disinfection equipment 213
TABLE 96 OTHER CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 214
7.3.3 LUBRICANTS & CLEANING SOLUTIONS 214
7.3.3.1 Lubrication is an important prerequisite during medical device reprocessing 214
TABLE 97 LUBRICANTS & CLEANING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 215
TABLE 98 LUBRICANTS & CLEANING SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 216
7.3.4 DISINFECTION & CLEANING ACCESSORIES 216
TABLE 99 DISINFECTION & CLEANING ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 217
7.4 PROTECTIVE BARRIERS 217
TABLE 100 PROTECTIVE BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 218
TABLE 101 PROTECTIVE BARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 218
7.4.1 MEDICAL NONWOVENS 219
TABLE 102 MEDICAL NONWOVENS MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 103 MEDICAL NONWOVENS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 220
7.4.1.1 Face masks 220
7.4.1.1.1 Face masks segment to dominate the medical nonwovens market due to the COVID-19 pandemic 220
TABLE 104 FACE MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 221
7.4.1.2 Surgical gowns 222
7.4.1.2.1 Rising adoption of nonwovens in surgical interventions is driving market growth 222
TABLE 105 LEVELS OF SURGICAL GOWNS 222
TABLE 106 SURGICAL GOWNS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 223
7.4.1.3 Surgical drapes 224
7.4.1.3.1 Rising adoption of disposable drapes is expected to aid market growth during the forecast period 224
TABLE 107 SURGICAL DRAPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 225
7.4.2 GLOVES 225
7.4.2.1 Increasing stringent regulations for personnel safety is driving the widespread adoption of gloves 225
TABLE 108 GLOVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 226
7.4.3 COVERS & CLOSURES 226
7.4.3.1 Growing number of surgical procedures to support market growth 226
TABLE 109 COVERS & CLOSURES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 227
7.4.4 GOGGLES 227
7.4.4.1 Increasing use of protective gear in research laboratories and hospitals to positively impact the market growth 227
TABLE 110 GOGGLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 228
7.5 ENDOSCOPE REPROCESSING PRODUCTS 228
TABLE 111 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 112 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 229
7.5.1 ENDOSCOPE REPROCESSING CONSUMABLES 230
7.5.1.1 Increasing number of endoscopy procedures conducted to drive market growth 230
TABLE 113 ENDOSCOPE REPROCESSING CONSUMABLES OFFERED BY KEY MARKET PLAYERS 230
TABLE 114 ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 231
7.5.2 ENDOSCOPE REPROCESSING EQUIPMENT 232
TABLE 115 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 116 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 232
7.5.2.1 Automated endoscope reprocessors 233
7.5.2.1.1 AERs enable high-level disinfection of heat-sensitive endoscopes and help minimize human errors 233
TABLE 117 AUTOMATED ENDOSCOPE REPROCESSORS OFFERED BY KEY MARKET PLAYERS 234
TABLE 118 AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 235
7.5.2.2 Endoscope tracking systems 235
7.5.2.2.1 Endoscope tracking systems reduce reprocessing errors and damage to endoscope inventory 235
TABLE 119 ENDOSCOPE TRACKING SYSTEMS OFFERED BY KEY MARKET PLAYERS 236
TABLE 120 ENDOSCOPE TRACKING SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 236
7.5.3 OTHER ENDOSCOPE REPROCESSING PRODUCTS 237
TABLE 121 OTHER ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS 238
TABLE 122 OTHER ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 239
7.6 OTHER INFECTION CONTROL PRODUCTS 239
TABLE 123 OTHER INFECTION CONTROL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 240
8 INFECTION CONTROL MARKET, BY END USER 241
8.1 INTRODUCTION 242
TABLE 124 INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 242
8.2 IMPACT OF COVID-19 ON THE END USERS OF THE INFECTION CONTROL MARKET 243
8.3 HOSPITALS & CLINICS 243
8.3.1 HIGH PREVALENCE OF HAIS HAS DRIVEN THE DEMAND FOR STERILIZATION AND DISINFECTION PRODUCTS & SERVICES 243
TABLE 125 EXAMPLES OF CRITICAL ACCESS HOSPITALS IMPLEMENTING EVIDENCE-BASED PROGRAMS TARGETING HAIS 245
TABLE 126 INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 246
8.4 MEDICAL DEVICE COMPANIES 247
8.4.1 GROWING OUTSOURCING OF STERILIZATION SERVICES BY THIS END-USER SEGMENT TO PROPEL MARKET GROWTH 247
TABLE 127 DIFFERENT METHODS OF STERILIZATION IN MEDICAL DEVICE COMPANIES 247
TABLE 128 INFECTION CONTROL MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 248
8.5 PHARMACEUTICAL COMPANIES 249
8.5.1 GROWING NEED TO ENSURE THE SAFETY OF MANUFACTURED PRODUCTS IS DRIVING THE ADOPTION OF INFECTION CONTROL PRODUCTS 249
TABLE 129 DIFFERENT METHODS OF STERILIZATION IN PHARMACEUTICAL COMPANIES 249
TABLE 130 INFECTION CONTROL MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 251
8.6 LIFE SCIENCES INDUSTRY 251
8.6.1 NEED FOR A CLEAN AND STERILE RESEARCH ENVIRONMENT IS DRIVING THE ADOPTION OF INFECTION CONTROL PRODUCTS 251
TABLE 131 INFECTION CONTROL MARKET FOR LIFE SCIENCES INDUSTRY, BY COUNTRY, 2019–2026 (USD MILLION) 253
8.7 FOOD INDUSTRY 253
8.7.1 INCREASING INCIDENCE OF FOOD- & WATER-BORNE DISEASES TO AID MARKET GROWTH 253
TABLE 132 INFECTION CONTROL MARKET FOR FOOD INDUSTRY, BY COUNTRY,
2019–2026 (USD MILLION) 255
8.8 OTHER END USERS 256
TABLE 133 INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY,
2019–2026 (USD MILLION) 257
9 INFECTION CONTROL MARKET, BY REGION 258
9.1 INTRODUCTION 259
FIGURE 34 INFECTION CONTROL MARKET: GEOGRAPHIC SNAPSHOT (2020) 259
TABLE 134 INFECTION CONTROL MARKET, BY REGION, 2019–2026 (USD MILLION) 260
9.2 IMPACT OF COVID-19 ON THE INFECTION CONTROL MARKET 260
9.3 NORTH AMERICA 262
FIGURE 35 NORTH AMERICA: INFECTION CONTROL MARKET SNAPSHOT 263
TABLE 135 NORTH AMERICA: INFECTION CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 263
TABLE 136 NORTH AMERICA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 264
TABLE 137 NORTH AMERICA: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 264
TABLE 138 NORTH AMERICA: STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 264
TABLE 139 NORTH AMERICA: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 140 NORTH AMERICA: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 141 NORTH AMERICA: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 142 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 266
TABLE 143 NORTH AMERICA: STERILIZATION INDICATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 266
TABLE 144 NORTH AMERICA: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 266
TABLE 145 NORTH AMERICA: DISINFECTANTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 267
TABLE 146 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 267
TABLE 147 NORTH AMERICA: DISINFECTANTS MARKET, BY EPA CLASSIFICATION,
2019–2026 (USD MILLION) 267
TABLE 148 NORTH AMERICA: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 149 NORTH AMERICA: ENDOSCOPE REPROCESSING PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 150 NORTH AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 151 NORTH AMERICA: PROTECTIVE BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 269
TABLE 152 NORTH AMERICA: MEDICAL NONWOVENS MARKET, BY TYPE,
2019–2026 (USD MILLION) 269
TABLE 153 NORTH AMERICA: INFECTION CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 269
9.3.1 US 270
9.3.1.1 The US dominates the North American infection control market 270
TABLE 154 US: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 271
TABLE 155 US: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 271
TABLE 156 US: STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 272
TABLE 157 US: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 272
TABLE 158 US: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 272
TABLE 159 US: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 160 US: CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 161 US: STERILIZATION INDICATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 162 US: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 274
TABLE 163 US: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 274
TABLE 164 US: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION) 274
TABLE 165 US: DISINFECTANTS MARKET, BY EPA CLASSIFICATION,
2019–2026 (USD MILLION) 275
TABLE 166 US: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 275
TABLE 167 US: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 275
TABLE 168 US: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 276
TABLE 169 US: PROTECTIVE BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 276
TABLE 170 US: MEDICAL NONWOVENS MARKET, BY TYPE, 2019–2026 (USD MILLION) 276
TABLE 171 US: INFECTION CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 277
9.3.2 CANADA 277
9.3.2.1 High prevalence of HAIs to increase the adoption of ICP products in the country 277
TABLE 172 CANADA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 278
TABLE 173 CANADA: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 174 CANADA: STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 279
TABLE 175 CANADA: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 279
TABLE 176 CANADA: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 177 CANADA: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 280
TABLE 178 CANADA: CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 280
TABLE 179 CANADA: STERILIZATION INDICATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 280
TABLE 180 CANADA: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 281
TABLE 181 CANADA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 281
TABLE 182 CANADA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 281
TABLE 183 CANADA: DISINFECTANTS MARKET, BY EPA CLASSIFICATION,
2019–2026 (USD MILLION) 282
TABLE 184 CANADA: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 282
TABLE 185 CANADA: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 282
TABLE 186 CANADA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 283
TABLE 187 CANADA: PROTECTIVE BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 188 CANADA: MEDICAL NONWOVENS MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 189 CANADA: INFECTION CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 284
9.4 EUROPE 284
TABLE 190 EUROPE: INFECTION CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 285
TABLE 191 EUROPE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 285
TABLE 192 EUROPE: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 286
TABLE 193 EUROPE: STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 286
TABLE 194 EUROPE: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 286
TABLE 195 EUROPE: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 287
TABLE 196 EUROPE: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 287
TABLE 197 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 287
TABLE 198 EUROPE: STERILIZATION INDICATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 288
TABLE 199 EUROPE: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 288
TABLE 200 EUROPE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 288
TABLE 201 EUROPE: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 289
TABLE 202 EUROPE: DISINFECTANTS MARKET, BY EPA CLASSIFICATION,
2019–2026 (USD MILLION) 289
TABLE 203 EUROPE: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 289
TABLE 204 EUROPE: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 205 EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 290
TABLE 206 EUROPE: PROTECTIVE BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 207 EUROPE: MEDICAL NONWOVENS MARKET, BY TYPE,
2019–2026 (USD MILLION) 291
TABLE 208 EUROPE: INFECTION CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 291

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127